Endonovo Therapeutics, Inc.

0.0002+0.00 (+0%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · ENDV · USD

Upcoming Earnings

Report date
≈ -

Key Stats

Market Cap
289.14K
P/E (TTM)
-
Basic EPS (TTM)
0.00
Dividend Yield
0%

Recent Filings

About

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

CEO
Mr. Alan Brian Collier
IPO
11/15/2012
Sector
Healthcare
Industry
Biotechnology